References
- Goldfine A B, Kahn C R. Adiponectin: linking the fat cell to insulin sensitivity. Lancet 2003; 362: 1431–1432
- Ouchi N, Kihara S, Arita Y, Maeda K, et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999; 100: 2473–2476
- Ouchi N, Kihara S, Arita Y, et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 2001; 103: 1057–1063
- Matsuzawa Y, Shimomura I, Kihara S, Funahashi T. Importance of adipocytokines in obesity-related diseases. Horm Res 2003; 3: 56–59
- Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 2006; 116: 1784–1792
- Bråkenhielm E, Veitonmäki N, Cao R, et al. Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. Proc Natl Acad Sci USA 2004; 101: 2476–2481
- Cnop M, Havel P J, Utzschneider K M, et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003; 46: 459–469
- Mantzoros C, Petridou E, Dessypris N, et al. Adiponectin and breast cancer risk. J Clin Endocrinol Metab 2004; 89: 1102–1107
- Dal Maso L, Augustin L S, Karalis A, et al. Circulating adiponectin and endometrial cancer risk. J Clin Endocrinol Metab 2004; 89: 1160–1163
- Otake S, Takeda H, Suzuki Y, et al. Association of visceral fat accumulation and plasma adiponectin with colorectal adenoma: evidence for participation of insulin resistance. Clin Cancer Res 2005; 11: 3642–3646
- Wei E K, Giovannucci E, Fuchs C S, Willet W C, Mantzoros C S. Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J Natl Cancer Inst 2005; 97: 1688–1694
- Lukanova A, Söderberg S, Kaaks R, Jellum E, Stattin P. Serum adiponectin is not associated with risk of colorectal cancer. Cancer Epidemiol Biomark Prev 2006; 15: 401–402
- Fukumoto J, Otake T, Tajima O, et al. Adiponectin and colorectal adenomas: Self Defense Forces Health Study. Cancer Sci 2008; 99: 781–786
- Ogunwobi O O, Beales I L. Adiponectin stimulates proliferation and cytokine secretion in colonic epithelial cells. Regul Pept 2006; 134: 105–113
- Yamauchi T, Kamon J, Ito Y, et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003; 423: 762–769
- Williams C J, Mitsiades N, Sozopoulos E, et al. Adiponectin receptor expression is elevated in colorectal carcinomas but not in gastrointestinal stromal tumors. Endocr Relat Cancer 2008; 15: 289–299
- Umar A, Boland C L, Terdiman J P, et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004; 96: 261–268
- Hamilton S R, Vogelstein B, Kudo S, et al. Tumors of the Digestive System. IARC Press, Lyon 2000; 39–52
- Corbetta S, Bulfamante G, Cortelazzi D, et al. Adiponectin expression in human fetal tissues during mid- and late gestation. J Clin Endocrinol Metab 2005; 90: 2397–2402
- Weir E E, Pretlow T G, Pitts A. A more sensitive and specific histochemical peroxidase stain for the localization of cellular antigen by the enzyme-antibody conjugated method. J Histochem Cytochem 1974; 22: 1135–1140
- Barresi V, Cerasoli S, Vitarelli E, Tuccari G. Density of microvessels positive for CD105 (endoglin) is related to prognosis in meningiomas. Acta Neuropathol 2007; 114: 147–156
- Barresi V, Vitarelli E, Tuccari G, Barresi G. Correlative study of microvessel density and 5-lipoxygenase expression in human sporadic colorectal cancer. Arch Pathol Lab Med 2008, in press
- Weidner N, Semple J P, Welch W R, Folkman J. Tumor angiogenesis and metastasis- correlation in invasive breast carcinoma. N Engl J Med 1991; 324: 1–8
- Housa D, Vernerová Z, Heráček J, et al. Adiponectin as a potential marker of prostate cancer progression: studies in organ-confined and locally advanced prostate cancer. Physiol Res Apr 25, 2007, [Epub ahead of print]
- Michalakis K, Williams C J, Mitsiades N, et al. Serum adiponectin concentrations and tissue expression of adiponectin receptors are reduced in patients with prostate cancer: a case control study. Cancer Epidemiol Biomark Prev 2007; 16: 308–313
- Körner A, Pazaitou-Panayiotou K, Kelesidis T, et al. Total and high-molecular-weight adiponectin in breast cancer: in vitro and in vivo studies. J Clin Endocrinol Metab 2007; 92: 1041–1048
- Petridou E T, Mitsiades N, Gialamas S, et al. Circulating adiponectin levels and expression of adiponectin receptors in relation to lung cancer: two case-control studies. Oncology 2007; 73: 261–269
- Mistry T, Digby J E, Chen J, Deasi K M, Randeva H S. The regulation of adiponectin receptors in human prostate cancer cell lines. Biochem Biophys Res Commun 2006; 348: 832–838
- Ryden M, Dicker A, Götherström C, et al. Functional characterization of human mesenchymal stem cell-derived adipocytes. Biochem Biophys Res Commun 2003; 311: 391–397
- Cong L, Gasser J, Zhao J, Yang B, Li F, Zhao A Z. Human adiponectin inhibits cell growth and induces apoptosis in human endomentrial carcinoma cells, HEC-1-A and RL95 2. Endocr Relat Cancer 2007; 14: 713–720
- Grossmann M E, Nkhata K J, Mizuno N K, Ray A, Cleary M P. Effects of adiponectin on breast cancer cell growth and signaling. Br J Cancer 2008; 98: 370–379
- DiMascio L, Voermans C, Uqoezwa M, et al. Identification of adiponectin as a novel hemopoietic stem cell growth factor. J Immunol 2007; 178: 3511–3520
- Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992; 267: 10931–10934
- Cheifetz S, Bellon T, Cales C, et al. Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. J Biol Chem 1992; 267: 19027–19030
- Miller D W, Graulich W, Karges B, et al. Elevated expression of endoglin, a component of the TGF-β receptor complex, correlates with proliferation of tumor endothelial cells. Int J Cancer 1999; 81: 568–572
- Saad R S, Liu Y L, Nathan G, Celebrezze J, Medich D, Silverman J F. Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in colorectal cancer. Mod Pathol 2004; 17: 197–203
- Motoshima H, Wu X, Mahadev K, Goldstein B J. Adiponectin suppresses proliferation and superoxide generation and enhances eNOS activity in endothelial cells treated with oxidized LDL. Biochem Biophys Res Commun 2004; 315: 264–271